Biodexa Pharmaceuticals Statistics

Total Valuation

BDRX has a market cap or net worth of $822,367. The enterprise value is -$5.08 million.

Market Cap	822,367
Enterprise Value	-5.08M

Important Dates

The next estimated earnings date is Monday, April 21, 2025, before market open.

Earnings Date	Apr 21, 2025
Ex-Dividend Date	n/a

Share Statistics

BDRX has 668,591 shares outstanding.

Current Share Class	n/a
Shares Outstanding	668,591
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	4.67%
Float	416,088

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.24
Forward PS	n/a
PB Ratio	0.04
P/TBV Ratio	0.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.04.

Current Ratio	2.16
Quick Ratio	2.16
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-96.81

Financial Efficiency

Return on equity (ROE) is -97.23% and return on invested capital (ROIC) is -55.03%.

Return on Equity (ROE)	-97.23%
Return on Assets (ROA)	-37.52%
Return on Invested Capital (ROIC)	-55.03%
Return on Capital Employed (ROCE)	-62.77%
Revenue Per Employee	$4,995
Profits Per Employee	-$410,371
Employee Count	21
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-307,101
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.27% in the last 52 weeks. The beta is 1.50, so BDRX's price volatility has been higher than the market average.

Beta (5Y)	1.50
52-Week Price Change	-94.27%
50-Day Moving Average	3.39
200-Day Moving Average	9.16
Relative Strength Index (RSI)	24.12
Average Volume (20 Days)	3,419,294

Short Selling Information

Short Interest	62,096
Short Previous Month	36,118
Short % of Shares Out	9.29%
Short % of Float	14.92%
Short Ratio (days to cover)	0.04

Income Statement

In the last 12 months, BDRX had revenue of $104,895 and -$8.62 million in losses. Loss per share was -$45.20.

Revenue	104,895
Gross Profit	183,250
Operating Income	-8.32M
Pretax Income	-9.56M
Net Income	-8.62M
EBITDA	-8.14M
EBIT	-8.32M
Loss Per Share	-$45.20

Full Income Statement

Balance Sheet

The company has $6.39 million in cash and $482,768 in debt, giving a net cash position of $5.91 million or $8.83 per share.

Cash & Cash Equivalents	6.39M
Total Debt	482,768
Net Cash	5.91M
Net Cash Per Share	$8.83
Equity (Book Value)	11.03M
Book Value Per Share	30.42
Working Capital	5.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.80 million and capital expenditures -$27,803, giving a free cash flow of -$10.06 million.

Operating Cash Flow	-9.80M
Capital Expenditures	-27,803
Free Cash Flow	-10.06M
FCF Per Share	-$15.05

Full Cash Flow Statement

Margins

Gross Margin	174.70%
Operating Margin	-7,931.30%
Pretax Margin	-8,508.41%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BDRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1,047.93%
FCF Yield	-1,223.76%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	-70.05%
EPS Growth Forecast (5Y)	-68.17%

Stock Forecasts

Stock Splits

The last stock split was on October 4, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Oct 4, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

BDRX has an Altman Z-Score of -15.64 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.64
Piotroski F-Score	1